Plastic neuronal changes in GABAA receptor gene expression induced by progesterone metabolites: In vitro molecular and functional studies

Pharmacology Biochemistry and Behavior

Volumn 84, Issue 4, 2006, Pages 545-554

  Biggio, Francesca ^a   Gorini, Giorgio ^a   Caria, Stefania ^a   Murru, Luca ^a   Mostallino, Maria Cristina ^b   Sanna, Enrico ^a   Follesa, Paolo ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CNR   (Italy)

Author keywords

Cell culture; GABAA receptor; Gene expression; Neurosteroids; Patch clamp; Synaptic plasticity

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; PROGESTERONE; COMPLEMENTARY DNA; DELTA SUBUNIT, GABA A RECEPTOR; DELTA SUBUNIT, GABA-A RECEPTOR; DEOXYCORTICOSTERONE; DRUG DERIVATIVE; ELTANOLONE; MESSENGER RNA; TETRAHYDRODEOXYCORTICOSTERONE;

AFFECT; ANIMAL CELL; ARTICLE; CELL POPULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMOTION; GENE EXPRESSION; MOLECULAR BIOLOGY; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PLASMA; PRIORITY JOURNAL; PROGESTERONE METABOLISM; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STIMULUS; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL GRANULE; CEREBELLUM; CYTOLOGY; DRUG EFFECT; ELECTROPHYSIOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PATCH CLAMP; WITHDRAWAL SYNDROME;

ANIMALS; CELLS, CULTURED; CEREBELLUM; CYTOPLASMIC GRANULES; DESOXYCORTICOSTERONE; DNA, COMPLEMENTARY; ELECTROPHYSIOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; NEURONAL PLASTICITY; PATCH-CLAMP TECHNIQUES; PREGNANOLONE; PROGESTERONE; RATS; RECEPTORS, GABA-A; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 34548578181     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.07.002     Document Type: Article

References (80)

1. Adkins C.E., Pillai G.V., Kerby J., Bonnert T.P., Haldon C., McKernan R.M., et al. Alpha4beta3delta GABA(A) receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential. J Biol Chem 276 (2001) 38934-38939
2. Azzolina B., Ellsworth K., Andersson S., Geissler W., Bull H.G., and Harris G.S. Inhibition of rat alpha-reductases by finasteride: evidence for isozyme differences in the mechanism of inhibition. J Steroid Biochem Mol Biol 61 (1997) 55-64
3. Banerjee P.K., Olsen R.W., Tillakaratne N.J., Brailowsky S., Tobin A.J., and Snead III O.C. Absence seizures decrease steroid modulation of t-[35S]butylbicyclophosphorothionate binding in thalamic relay nuclei. J Pharmacol Exp Ther 287 (1998) 766-772
4. Barbaccia M.L., Roscetti G., Trabucchi M., Mostallino M.C., Concas A., Purdy R.H., et al. Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. Neuroendocrinology 63 (1996) 166-172
5. Barnard E.A., Skolnick P., Olsen R.W., Mohler H., Sieghart W., Biggio G., et al. International Union of Pharmacology: XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50 (1998) 291-313
6. Belelli D., Casula A., Ling A., and Lambert J.J. The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors. Neuropharmacology 43 (2002) 651-661
7. Bicikova M., Dibbelt L., Hill M., Hampl R., and Starka L. Allopregnanolone in women with premenstrual syndrome. Horm Metab Res 30 (1998) 227-230
8. Bitran D., Purdy R.H., and Kellogg C.K. Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function. Pharmacol Biochem Behav 45 (1993) 423-428
9. Bitran D., Shiekh M., and McLeod M. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J Neuroendocrinol 7 (1995) 171-177
10. Bovolin P., Santi M.R., Puia G., Costa E., and Grayson D. Expression patterns of gamma-aminobutyric acid type A receptor subunit mRNAs in primary cultures of granule neurons and astrocytes from neonatal rat cerebella. Proc Natl Acad Sci U S A 89 (1992) 9344-9348
11. Braestrup C., Schmiechen R., Neef G., Nielsen M., and Petersen E.N. Interaction of convulsive ligands with benzodiazepine receptors. Science 216 (1982) 1241-1243
12. Braestrup C., Nielsen M., and Honore T. Binding of [3H]DMCM, a convulsive benzodiazepine ligand, to rat brain membranes: preliminary studies. J Neurochem 41 (1983) 454-465
13. Brambilla F., Biggio G., Pisu M.G., Bellodi L., Perna G., Bogdanovich-Djukic V., et al. Neurosteroid secretion in panic disorder. Psychiatry Res 118 (2003) 107-116
14. Brickley S.G., Revilla V., Cull-Candy S.G., Wisden W., and Farrant M. Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 409 (2001) 88-92
15. Brown N., Kerby J., Bonnert T.P., Whiting P.J., and Wafford K.A. Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors. Br J Pharmacol 136 (2002) 965-974
16. Brussaard A.B., and Herbison A.E. Long-term plasticity of postsynaptic GABAA-receptor function in the adult brain: insights from the oxytocin neurone. Trends Neurosci 23 (2000) 190-195
17. Brussaard A.B., Kits K.S., Baker R.E., Willems W.P., Leyting-Vermeulen J.W., Voorn P., et al. Plasticity in fast synaptic inhibition of adult oxytocin neurons caused by switch in GABA(A) receptor subunit expression. Neuron 19 (1997) 1103-1114
18. Cagetti E., Liang J., Spigelman I., and Olsen R.W. Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors. Mol Pharmacol 63 (2003) 53-64
19. Concas A., Mostallino M.C., Porcu P., Follesa P., Barbaccia M.L., Trabucchi M., et al. Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci U S A 95 (1998) 13284-13289
20. Devaud L.L., Purdy R.H., Finn D.A., and Morrow A.L. Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal. J Pharmacol Exp Ther 278 (1996) 510-517
21. Fenelon V.S., and Herbison A.E. Plasticity in GABAA receptor subunit mRNA expression by hypothalamic magnocellular neurons in the adult rat. J Neurosci 16 (1996) 4872-4880
22. Follesa P., Floris S., Tuligi G., Mostallino M.C., Concas A., and Biggio G. Molecular and functional adaptation of the GABA(A) receptor complex during pregnancy and after delivery in the rat brain. Eur J Neurosci 10 (1998) 2905-2912
23. Follesa P., Serra M., Cagetti E., Pisu M.G., Porta S., Floris S., et al. Allopregnanolone synthesis in cerebellar granule cells: roles in regulation of GABA(A) receptor expression and function during progesterone treatment and withdrawal. Mol Pharmacol 57 (2000) 1262-1270
24. Follesa P., Concas A., Porcu P., Sanna E., Serra M., Mostallino M.C., et al. Role of allopregnanolone in regulation of GABA(A) receptor plasticity during long-term exposure to and withdrawal from progesterone. Brain Res Brain Res Rev 37 (2001) 81-90
25. Follesa P., Mancuso L., Biggio F., Mostallino M.C., Manca A., Mascia M.P., et al. Gamma-hydroxybutyric acid and diazepam antagonize a rapid increase in GABA(A) receptors alpha(4) subunit mRNA abundance induced by ethanol withdrawal in cerebellar granule cells. Mol Pharmacol 63 (2003) 896-907
26. Follesa P., Mostallino M.C., Biggio F., Gorini G., Caria S., Busonero F., et al. Distinct patterns of expression and regulation of GABA receptors containing the delta subunit in cerebellar granule and hippocampal neurons. J Neurochem 94 (2005) 659-671
27. Freeman E.W., Purdy R.H., Coutifaris C., Rickels K., and Paul S.M. Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. Neuroendocrinology 58 (1993) 478-484
28. Friedman L., Gibbs T.T., and Farb D.H. Gamma-aminobutyric acidA receptor regulation: chronic treatment with pregnanolone uncouples allosteric interactions between steroid and benzodiazepine recognition sites. Mol Pharmacol 44 (1993) 191-197
29. Friedman L.K., Gibbs T.T., and Farb D.H. Gamma-aminobutyric acidA receptor regulation: heterologous uncoupling of modulatory site interactions induced by chronic steroid, barbiturate, benzodiazepine, or GABA treatment in culture. Brain Res 707 (1996) 100-109
30. Gee K.W., and Lan N.C. Gamma-aminobutyric acidA receptor complexes in rat frontal cortex and spinal cord show differential responses to steroid modulation. Mol Pharmacol 40 (1991) 995-999
31. Hammer F., Compagnone N.A., Vigne J.L., Bair S.R., and Mellon S.H. Transcriptional regulation of P450scc gene expression in the embryonic rodent nervous system. Endocrinology 145 (2004) 901-912
32. Harrison N.L., and Simmonds MA. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res 323 (1984) 287-292
33. Hu Z.Y., Bourreau E., Jung-Testas I., Robel P., and Baulieu EE. Neurosteroids: oligodendrocyte mitochondria convert cholesterol to pregnenolone. Proc Natl Acad Sci U S A 84 (1987) 8215-8219
34. Jones A., Korpi E.R., McKernan R.M., Pelz R., Nusser Z., Makela R., et al. Ligand-gated ion channel subunit partnerships: GABAA receptor alpha6 subunit gene inactivation inhibits delta subunit expression. J Neurosci 17 (1997) 1350-1362
35. Kokate T.G., Banks M.K., Magee T., Yamaguchi S., and Rogawski M.A. Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J Pharmacol Exp Ther 288 (1999) 679-684
36. Lambert J.J., Belelli D., Hill-Venning C., and Peters J.A. Neurosteroids and GABAA receptor function. Trends Pharmacol Sci 16 (1995) 295-303
37. Laurie D.J., Seeburg P.H., and Wisden W. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain: II. Olfactory bulb and cerebellum. J Neurosci 12 (1992) 1063-1076
38. Laurie D.J., Wisden W., and Seeburg P.H. The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain: III. Embryonic and postnatal development. J Neurosci 12 (1992) 4151-4172
39. Low K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290 (2000) 131-134
40. Majewska M.D. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol 38 (1992) 379-395
41. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
42. Mascia M.P., Biggio F., Mancuso L., Cabras S., Cocco P.L., Gorini G., et al. Changes in GABA(A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, ganaxolone in cultured rat cerebellar granule cells. J Pharmacol Exp Ther 303 (2002) 1014-1020
43. McKernan R.M., Rosahl T.W., Reynolds D.S., Sur C., Wafford K.A., Atack J.R., et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 3 (2000) 587-592
44. Mihalek R.M., Banerjee P.K., Korpi E.R., Quinlan J.J., Firestone L.L., Mi Z.P., et al. Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci U S A 96 (1999) 12905-12910
45. Monteleone P., Luisi S., Tonetti A., Bernardi F., Genazzani A.D., Luisi M., et al. Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 142 (2000) 269-273
46. Mtchedlishvili Z., Bertram E.H., and Kapur J. Diminished allopregnanolone enhancement of GABA(A) receptor currents in a rat model of chronic temporal lobe epilepsy. J Physiol 537 (2001) 453-465
47. Nusser Z., and Mody I. Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells. J Neurophysiol 87 (2002) 2624-2628
48. Nusser Z., Sieghart W., and Somogyi P. Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci 18 (1998) 1693-1703
49. Picazo O., and Fernandez-Guasti A. Anti-anxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test. Brain Res 680 (1995) 135-141
50. Pisu M.G., and Serra M. Neurosteroids and neuroactive drugs in mental disorders. Life Sci 74 (2004) 3181-3197
51. Pritchett D.B., Sontheimer H., Shivers B.D., Ymer S., Kettenmann H., Schofield P.R., et al. Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature 338 (1989) 582-585
52. Rapkin A.J., Morgan M., Goldman L., Brann D.W., Simone D., and Mahesh V.B. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90 (1997) 709-714
53. Reddy D.S., and Rogawski M.A. Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy. J Pharmacol Exp Ther 294 (2000) 909-915
54. Rittmaster R.S. Finasteride. N Engl J Med 330 (1994) 120-125
55. Romeo E., Strohle A., Spalletta G., di Michele F., Hermann B., Holsboer F., et al. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155 (1998) 910-913
56. Rudolph U., Crestani F., Benke D., Brunig I., Benson J.A., Fritschy J.M., et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401 (1999) 796-800
57. Rupprecht R., Reul J.M., Trapp T., van Steensel B., Wetzel C., Damm K., et al. Progesterone receptor-mediated effects of neuroactive steroids. Neuron 11 (1993) 523-530
58. Rupprecht R., Hauser C.A., Trapp T., and Holsboer F. Neurosteroids: molecular mechanisms of action and psychopharmacological significance. J Steroid Biochem Mol Biol 56 (1996) 163-168
59. Sanne J.L., and Krueger KE. Expression of cytochrome P450 side-chain cleavage enzyme and 3 beta-hydroxysteroid dehydrogenase in the rat central nervous system: a study by polymerase chain reaction and in situ hybridization. J Neurochem 65 (1995) 528-536
60. Serra M., Pisu M.G., Littera M., Papi G., Sanna E., Tuveri F., et al. Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain. J Neurochem 75 (2000) 732-740
61. Smith S.S., Gong Q.H., Hsu F.C., Markowitz R.S., ffrench-Mullen J.M., and Li X. GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392 (1998) 926-930
62. Smith S.S., Gong Q.H., Li X., Moran M.H., Bitran D., Frye C.A., et al. Withdrawal from 3alpha-OH-5alpha-pregnan-20-one using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha 4 subunit in association with increased anxiety. J Neurosci 18 (1998) 5275-5284
63. Spigelman I., Li Z., Liang J., Cagetti E., Samzadeh S., Mihalek R.M., et al. Reduced inhibition and sensitivity to neurosteroids in hippocampus of mice lacking the GABA(A) receptor delta subunit. J Neurophysiol 90 (2003) 903-910
64. Stell B.M., Brickley S.G., Tang C.Y., Farrant M., and Mody I. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors. Proc Natl Acad Sci U S A 100 (2003) 14439-14444
65. Strohle A., Romeo E., Hermann B., Pasini A., Spalletta G., di Michele F., et al. Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry 45 (1999) 274-277
66. Strohle A., Romeo E., di Michele F., Pasini A., Yassouridis A., Holsboer F., et al. GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry 159 (2002) 145-147
67. Strohle A., Romeo E., di Michele F., Pasini A., Hermann B., Gajewsky G., et al. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results. Arch Gen Psychiatry 60 (2003) 161-168
68. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 95 (1998) 3239-3244
69. Vicini S., Losi G., and Homanics G.E. GABA(A) receptor delta subunit deletion prevents neurosteroid modulation of inhibitory synaptic currents in cerebellar neurons. Neuropharmacology 43 (2002) 646-650
70. Wafford K.A., Thompson S.A., Thomas D., Sikela J., Wilcox A.S., and Whiting P.J. Functional characterization of human gamma-aminobutyric acid A receptors containing the alpha 4 subunit. Mol Pharmacol 50 (1996) 670-678
71. Weiland N.G., and Orchinik M. Specific subunit mRNAs of the GABAA receptor are regulated by progesterone in subfields of the hippocampus. Brain Res Mol Brain Res 32 (1995) 271-278
72. Whittemore E.R., Yang W., Drewe J.A., and Woodward R.M. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes. Mol Pharmacol 50 (1996) 1364-1375
73. Wisden W., Laurie D.J., Monyer H., and Seeburg P.H. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain: I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12 (1992) 1040-1062
74. Wohlfarth K.M., Bianchi M.T., and Macdonald R.L. Enhanced neurosteroid potentiation of ternary GABA(A) receptors containing the delta subunit. J Neurosci 22 (2002) 1541-1549
75. Wu F.S., Gibbs T.T., and Farb D.H. Inverse modulation of gamma-aminobutyric acid-and glycine-induced currents by progesterone. Mol Pharmacol 37 (1990) 597-602
76. Yang W., Drewe J.A., and Lan N.C. Cloning and characterization of the human GABAA receptor alpha 4 subunit: identification of a unique diazepam-insensitive binding site. Eur J Pharmacol 291 (1995) 319-325
77. Yu R., Follesa P., and Ticku M.K. Down-regulation of the GABA receptor subunits mRNA levels in mammalian cultured cortical neurons following chronic neurosteroid treatment. Brain Res Mol Brain Res 41 (1996) 163-168
78. Yu R., Hay M., and Ticku M.K. Chronic neurosteroid treatment attenuates single cell GABAA response and its potentiation by modulators in cortical neurons. Brain Res 706 (1996) 160-162
79. Yu R., and Ticku M.K. Chronic neurosteroid treatment decreases the efficacy of benzodiazepine ligands and neurosteroids at the gamma-aminobutyric acid A receptor complex in mammalian cortical neurons. J Pharmacol Exp Ther 275 (1995) 784-789
80. Yu R., and Ticku M.K. Chronic neurosteroid treatment produces functional heterologous uncoupling at the gamma-aminobutyric acid type A/benzodiazepine receptor complex in mammalian cortical neurons. Mol Pharmacol 47 (1995) 603-610